Actions Taken On HPV Vaccine Proposals In Arkansas, Colorado; Merck Lobbying Funding Reported In New York
The following highlights recent state news related to human papillomavirus vaccines. Merck’s HPV vaccine Gardasil and GlaxoSmithKline’s HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases. [click link for full article]